DNA topoisomerase inhibitors.
D'Incalci
M
M
Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.
Capranico
G
G
Giaccone
G
G
Zunino
F
F
Garattini
S
S
D000818:Animals; D018943:Anthracyclines; D000880:Anthraquinones; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects / Q000493:pharmacokinetics; D017321:Clinical Trials, Phase I as Topic; D004351:Drug Resistance / Q000502:physiology; D006801:Humans; D011034:Podophyllotoxin / Q000009:adverse effects / Q000031:analogs & derivatives / Q000493:pharmacokinetics; D059004:Topoisomerase I Inhibitors
D018943:Anthracyclines; D000880:Anthraquinones; D000903:Antibiotics, Antineoplastic; D059004:Topoisomerase I Inhibitors; C055925:anthrapyrazole; D011034:Podophyllotoxin